• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Biobanking in the COVID-19 Era and Beyond: Part 2. A Set of Tool Implementation Case Studies.新冠疫情时代及之后的生物样本库:第二部分。一组工具实施案例研究。
Biopreserv Biobank. 2020 Dec;18(6):547-560. doi: 10.1089/bio.2020.0083. Epub 2020 Nov 18.
2
Biobanking in the COVID-19 Era and Beyond: Part 1. How Early Experiences Can Translate into Actionable Wisdom.新冠疫情时代及之后的生物样本库:第一部分。早期经验如何转化为可行的智慧。
Biopreserv Biobank. 2020 Dec;18(6):533-546. doi: 10.1089/bio.2020.0082. Epub 2020 Nov 6.
3
Diverse Responses of the Biobanks in Indo-Pacific Rim Region During the COVID-19 Pandemic: Case Scenarios from Two Low- and Middle-Income Countries and Two High-Income Countries in the Indo-Pacific Rim Region.新冠疫情期间印太地区生物样本库的多样反应:来自印太地区两个低收入和中等收入国家以及两个高收入国家的案例
Biopreserv Biobank. 2020 Dec;18(6):525-532. doi: 10.1089/bio.2020.0078. Epub 2020 Oct 28.
4
Opportunities and Risks for Research Biobanks in the COVID-19 Era and Beyond.新冠疫情时代及之后研究生物样本库面临的机遇与风险
Biopreserv Biobank. 2020 Dec;18(6):503-510. doi: 10.1089/bio.2020.0079. Epub 2020 Oct 8.
5
Data Sharing Solutions for Biobanks for the COVID-19 Pandemic.针对新冠疫情生物样本库的数据共享解决方案
Biopreserv Biobank. 2020 Dec;18(6):581-586. doi: 10.1089/bio.2020.0040. Epub 2020 Aug 19.
6
ISO 20387 biobanking standard. Analysis of requirements and experience of implementation.ISO 20387 生物库标准。需求分析与实施经验。
Klin Lab Diagn. 2020 Sep 16;65(9):587-592. doi: 10.18821/0869-2084-2020-65-9-587-592.
7
Standardization and Innovation in Paving a Path to a Better Future: An Update of Activities in ISO/TC276/WG2 Biobanks and Bioresources.为美好未来铺路的标准化与创新:ISO/TC276/WG2生物样本库和生物资源活动更新
Biopreserv Biobank. 2018 Feb;16(1):23-27. doi: 10.1089/bio.2017.0117. Epub 2018 Feb 2.
8
The Importance of Biobanking for Response to Pandemics Caused by Emerging Viruses: The European Virus Archive As an Observatory of the Global Response to the Zika Virus and COVID-19 Crisis.生物样本库在应对新兴病毒大流行中的重要性:欧洲病毒档案库作为全球应对寨卡病毒和新冠疫情危机的观察站
Biopreserv Biobank. 2020 Dec;18(6):561-569. doi: 10.1089/bio.2020.0119. Epub 2020 Nov 11.
9
A Study of Policies and Guidelines for Collecting, Processing, and Storing Coronavirus Disease 2019 Patient Biospecimens for Biobanking and Research.关于收集、处理和存储2019冠状病毒病患者生物样本用于生物样本库和研究的政策与指南研究
Biopreserv Biobank. 2020 Dec;18(6):511-516. doi: 10.1089/bio.2020.0099. Epub 2020 Dec 4.
10
Challenges to biobanking in LMICs during COVID-19: time to reconceptualise research ethics guidance for pandemics and public health emergencies?新冠肺炎疫情期间中低等收入国家生物库面临的挑战:是否需要重新构想大流行和突发公共卫生事件的研究伦理指南?
J Med Ethics. 2022 Jul;48(7):466-471. doi: 10.1136/medethics-2020-106858. Epub 2021 May 12.

引用本文的文献

1
The COVID-19 pandemic reveals the wide-ranging role of biobanks.新冠疫情揭示了生物银行的广泛作用。
Front Public Health. 2023 Sep 1;11:1256601. doi: 10.3389/fpubh.2023.1256601. eCollection 2023.
2
The Cooperative Human Tissue Network of the National Cancer Institute: Supporting Cancer Research for 35 Years.美国国家癌症研究所合作人类组织网络:支持癌症研究 35 年。
Mol Cancer Ther. 2023 Oct 2;22(10):1144-1153. doi: 10.1158/1535-7163.MCT-22-0714.
3
Purpose, Partnership, and Possibilities: The Implementation of the Dog Aging Project Biobank.目的、伙伴关系与可能性:犬类衰老项目生物样本库的实施
Biomark Insights. 2022 Nov 30;17:11772719221137217. doi: 10.1177/11772719221137217. eCollection 2022.

本文引用的文献

1
Biobanking in the COVID-19 Era and Beyond: Part 1. How Early Experiences Can Translate into Actionable Wisdom.新冠疫情时代及之后的生物样本库:第一部分。早期经验如何转化为可行的智慧。
Biopreserv Biobank. 2020 Dec;18(6):533-546. doi: 10.1089/bio.2020.0082. Epub 2020 Nov 6.
2
A Biobank's Journey: Implementation of a Quality Management System and Accreditation to ISO 20387.生物银行的发展历程:质量管理体系的实施和 ISO 20387 认证。
Biopreserv Biobank. 2021 Jun;19(3):163-170. doi: 10.1089/bio.2020.0068. Epub 2020 Nov 4.
3
Diverse Responses of the Biobanks in Indo-Pacific Rim Region During the COVID-19 Pandemic: Case Scenarios from Two Low- and Middle-Income Countries and Two High-Income Countries in the Indo-Pacific Rim Region.新冠疫情期间印太地区生物样本库的多样反应:来自印太地区两个低收入和中等收入国家以及两个高收入国家的案例
Biopreserv Biobank. 2020 Dec;18(6):525-532. doi: 10.1089/bio.2020.0078. Epub 2020 Oct 28.
4
A New Qualification for the New Year: ISBER and American Society of Clinical Pathology Board of Certification Announce New Qualification in Biorepository Science Examination for Biobank Technicians.新年新资质:国际生物和环境样本库协会(ISBER)与美国临床病理学会认证委员会宣布推出生物样本库科学考试新资质,面向生物样本库技术人员。
Biopreserv Biobank. 2020 Feb;18(1):43-44. doi: 10.1089/bio.2020.29063.bjs. Epub 2020 Jan 28.
5
Comparison and Analysis of Two Internationally Recognized Biobanking Standards.两种国际认可的生物样本库标准的比较与分析
Biopreserv Biobank. 2020 Apr;18(2):82-89. doi: 10.1089/bio.2019.0126. Epub 2020 Jan 27.
6
Assessing and measuring financial sustainability model of the Spanish HIV HGM BioBank.评估和衡量西班牙艾滋病毒人类遗传学生物银行的财务可持续性模型。
J Transl Med. 2020 Jan 6;18(1):6. doi: 10.1186/s12967-019-02187-w.
7
The Implementation of an Integrated Management System at Qatar Biobank.卡塔尔生物样本库综合管理系统的实施
Biopreserv Biobank. 2019 Dec;17(6):506-511. doi: 10.1089/bio.2019.0076.
8
Canadian Tissue Repository Network Biobank Certification Program: Update and Review of the Program from 2011 to 2018.加拿大组织储存库网络生物样本库认证计划:2011年至2018年该计划的更新与回顾
Biopreserv Biobank. 2019 Dec;17(6):530-538. doi: 10.1089/bio.2019.0015. Epub 2019 Jun 13.
9
Biobank Continuity Management: A Survey of Biobank Professionals.
Biopreserv Biobank. 2019 Oct;17(5):410-417. doi: 10.1089/bio.2018.0142. Epub 2019 Apr 24.
10
ISBER and the Biobanking and Cohort Network (BCNet): A Strengthened Partnership.国际生物与环境样本库协会(ISBER)与生物样本库和队列网络(BCNet):强化的伙伴关系。
Biopreserv Biobank. 2018 Oct;16(5):393-394. doi: 10.1089/bio.2018.29043.mkh.

新冠疫情时代及之后的生物样本库:第二部分。一组工具实施案例研究。

Biobanking in the COVID-19 Era and Beyond: Part 2. A Set of Tool Implementation Case Studies.

作者信息

Allocca Clare M, Snapes Emma, Albert Monique, Bledsoe Marianna J, Castelhano Marta G, De Wilde Mieke, Furuta Koh, Kozlakidis Zisis, Martin Dunja, Martins Anabela, McCall Shannon J, Schacter Brent

机构信息

Standards Coordination Office, National Institute of Standards and Technology, Gaithersburg, Maryland, USA.

BioConsulting, Cork, Ireland.

出版信息

Biopreserv Biobank. 2020 Dec;18(6):547-560. doi: 10.1089/bio.2020.0083. Epub 2020 Nov 18.

DOI:10.1089/bio.2020.0083
PMID:33226280
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7757526/
Abstract

The COVID-19 era has brought about a number of novel challenges for the global biobanking community. An array of diverse tools (e.g., standards, best practices, and plans) exists to support quality and fitness-for-purpose in biobank operations. The International Society for Biological and Environmental Repositories (ISBER) COVID-19 Response Task Force has set out to identify needs and gaps in these tools and make recommendations for the next generation of available tools, having closely examined the COVID-19-related challenges. While conducting this work to examine the relationships between tools and biobank adaptability, a subgroup of the task force conducted a parallel effort to develop and describe individual COVID-19 era case studies based on a number of operating biobanks. Each case study presents a different combination of implemented tools. Observations and lessons learned from these case studies are provided, and experiences with tool implementation are discussed. This information is supplemented by data relating to tool usefulness that was obtained through an ISBER survey discussed in a companion article. The knowledge gained from this study will be combined with other task force efforts to make recommendations to better position the biobanking community in their response to future emergencies.

摘要

新冠疫情时代给全球生物样本库界带来了诸多新挑战。现有一系列不同的工具(如标准、最佳实践和计划)来支持生物样本库运作中的质量和适用性。国际生物与环境样本库协会(ISBER)新冠疫情应对特别工作组已着手确定这些工具中的需求和差距,并针对下一代可用工具提出建议,该工作组已仔细研究了与新冠疫情相关的挑战。在开展这项研究以考察工具与生物样本库适应性之间的关系时,特别工作组的一个子组同时开展了另一项工作,即基于多个运营中的生物样本库来开发和描述新冠疫情时代的个案研究。每个案例研究展示了所实施工具的不同组合。文中提供了从这些案例研究中得出的观察结果和经验教训,并讨论了工具实施的经验。通过一篇配套文章中所讨论的ISBER调查获得的与工具实用性相关的数据,对这些信息起到了补充作用。从本研究中获得的知识将与特别工作组的其他工作相结合,以便提出建议,从而让生物样本库界在应对未来紧急情况时能处于更有利的位置。